A recent book about Lyme Disease sets forth credible information that the disease is an outgrowth of U.S. biological warfare research.
Bitten, The Secret History of Lyme Disease and Biological Weapons chronicles the career of Willy Burgdorfer, a Swiss-born expert on tick and flea-borne diseases who spent most of his career researching those areas as a U.S. biological warfare scientist.
” . . . . if Willy’s claim was true, a crime against humanity had been committed by the U.S. government, and then covered up. . . ” “Bitten,” p. 103.
Listeners are emphatically encouraged to purchase and read this book, as well as sharing it with others.
Author Kris Newby presents substantive evidence that the disease stems from BW research done by Burgdorfer and associates. (Burgdorfer was the scientist who “discovered” the organism that causes Lyme Disease.)
NB: The material in this broadcast is deliberately overlapped with that in the last program.
In this post, we highlight information about what Willy termed “the Swiss Agent”–a rickettsia that was present in the vast majority of Lyme sufferers tested early in research into the disease.
Eventually, discussion of the possible role of Swiss Agent dropped out of discussion. The disappearance of the Swiss Agent from the scientific analytical literature coincided with Willy’s telephone conversations with biological warfare research veterans.
Key points of discussion:
1.–” . . . . I would engage the scientific part of his brain in answering my two questions: why the Lyme discovery files were missing from the National Archives, and why images of the organism labeled ‘Swiss Agent’ were located in the archive folders in the time-frame where one would expect the Lyme spirochete pictures to be. . . .”
2.–” . . . . He told me that in late 1979, he had tested ‘over one hundred ticks’ from Shelter Island, located about twenty miles from the Lyme outbreak, and all but two had an unidentified rickettsial species inside. It looked like Rickettsia montana (now called Rickettsia montanensis) under a microscope, a non-disease-causing cousin of the deadly Rickettsia ricketsii, but it was a different species. . . .”
3.–” . . . .’You say they’re not looking for it anymore?’ I asked. ‘They probably paid people off,’ he said. ‘There are folks up there who have a way to enable that.’ . . .”
4.–” . . . . Next, I showed Willy an unlabeled image of a microbe and asked him what it was. ‘That is a Swiss Agent,’ said Willy. I asked him a series of questions on this microbe and he recited what seemed like well-rehearsed lines: the Swiss Agent is a Rickettsia montana-like organism found in the European sheep tick, Ixodes Ricinus, and it doesn’t cause disease in humans. . . .”
5.–” . . . . Then I asked him why he brought samples of it from Switzerland back to his lab. He replied with the response that he often used when he seemed to know the answer but wasn’t going to divulge it: ‘Question mark.’. . .”
6.–” . . . . The real ‘smoking gun,’ though, was Willy’s handwritten lab notes on the patient blood tests from the disease outbreak in Connecticut. These tests showed the proof-of-presence of what I named ‘Swiss Agent USA,’ the mystery rickettsia present in most of the patients from the original Lyme outbreak, a fact that was never disclosed in journal articles. It didn’t take a PhD in microbiology to see that almost all the patient blood had reacted strongly to an antigen test for a European rickettsia that Willy had called the Swiss Agent. . . .”
7.–” . . . . In March, he wrote to Anderson and Steere again: ‘Most specimens, with a few exceptions, reacted only against antigens prepared from the Swiss Agent.’ In short, the disease clusters in Connecticut and Long Island seemed to have been caused by Swiss Agent USA. Then, in April, the Swiss Agent USA rickettsia vanished. It was never again mentioned in talks, letters, interviews, or journal articles. . . . There is, without a doubt, something suspicious about the sudden disappearance of the Swiss Agent USA from all correspondence. . . .”
8.–The disappearance of the Swiss Agent USA from the literature on Lyme Disease corresponded with an important conversation that Willy had: ” . . . . It was in the beginning of 1980—two years before the first Lyme spirochetes were found—that the Swiss Agent USA disappeared. This about-face coincided with a series of discussions Willy had with old bioweapons developers on the Rickettsial Commission of the Armed Forces Epidemiological Board, as recorded in his personal phone log. These scientists were most certainly familiar with the secret history of incapacitating rickettsial and viral agent testing, and they may have discussed with Willy the possibility of there having been an undisclosed field test in the Long Island region. . . .”
9.–Roundworms similar to organisms studied by Willy at the Naval Research Unit in Cairo turned up in some of the ticks: ” . . . . That’s when Willy found parasitic roundworm larvae in the main body cavity of two of the ticks. They were similar to the deer worms he’d found in ticks on his 1978 trip to Switzerland, and similar to the roundworms that he, Sonenshine, and the Naval Research Unit in Cairo had worked with for a project exploring the ‘relatively new field of endo-parasitic transmission of disease agents.’ In these experiments, multiple disease agents were put inside mosquito-borne roundworms, according to an NIH research report from 1961. . . .”
10.–Numerically, it appears that the Swiss Agent rickettsias outnumbered the spirochetes that ultimately were tabbed as the causative agent for Lyme Disease: ” . . . . When Willy dissected 124 more Shelter Island deer ticks, 98 percent had the new rickettsias in them and only 60 percent carried the new spirochetes. Willy thought that either microbe might be causing Lyme disease, but, for unknown reasons, this alternative theory fell into a black hole. . . .”
Pivoting to discussion of the politics of Lyme Disease treatment, we note that legal and regulatory rulings have enabled the patenting of living organisms and that has exacerbated the monetizing of Lyme Disease treatment. That monetization, in turn, has adversely affected the quality of care for afflicted patients. As we will see later, Willy Burgdorfer was not the only Lyme Disease researcher to become involved with biological warfare research. ” . . . . All of a sudden, the institutions that were supposed to be protectors of public health became business partners with Big Pharma. The university researchers who had previously shared information on dangerous emerging diseases were now delaying publishing their findings so they could become entrepreneurs and profit from patents through their university technology transfer groups. We essentially lost our system of scientific checks and balances. And this, in turn, has undermined patient trust in the institutions that are supposed to ‘do no harm.’ . . .”
Ms. Newby went up against the “Lyme Disease establishment” in an attempt to find out why the disease was being mis-diagnosed and ineffectively treated. Strikingly, a FOIA suit she filed was stonewalled for five years, before finally yielding the documents she had so long sought.
The “experts” and their agenda was neatly, and alarmingly, summed up by Ms. Newby: ” . . . . The emails revealed a disturbing picture of a nonofficial group of government employees and guidelines authors that had been setting the national Lyme disease research agenda without public oversight or transparency. . . . Bottom line, the guidelines authors regularly convened in government-funded, closed-door meetings with hidden agendas that lined the pockets of academic researchers with significant commercial interests in Lyme disease tests and vaccines. A large percentage of government grants were awarded to the guideline authors and/or researchers in their labs. Part of the group’s stated mission, culled from these FOIA emails, was to run a covert ‘disinformation war’ and a ‘sociopolitical offensive’ to discredit Lyme patients, physicians, and journalists who questioned the group’s research and motives. In the FOIA-obtained emails, Lyme patients and their treating physicians were called ‘loonies’ and ‘quacks’ by Lyme guidelines authors and NIH employees. . . .”
Further developing the links between biological warfare research and the Lyme Disease establishment, we review information from FTR #585.
At every turn, Lyme disease research is inextricably linked with biological warfare research. Divided into the “Steere” and “ILADS” camps, the Lyme disease research community is split between the view that the disease is “hard-to-catch, easy-to-cure” and the diametrically opposed view that the disease is very serious and produces long-term neurological disorder. The Steere camp diminishes the significance of the disease and is closely identified with biological warfare research. At the epicenter of Lyme disease research (and the Steere camp) are members of the Epidemic Intelligence Service, or EIS. EIS personnel are to be found at every bend in the road of Lyme disease research.
The Borrelia genus has long been researched as a biological warfare vector.
” . . . . The Borrelia genus of bacteria, which encompasses the Borrelia burgdorferi species-group (to which Lyme disease is attributed), was studied by the infamous WW2 Japanese biowar Unit 731, who carried out horrific experiments on prisoners in Manchuria, including dissection of live human beings. [iii] Unit 731 also worked on a number of other tick-borne pathogens. . . . . borrelia were known for their ability to adopt different forms under conditions of stress (such as exposure to antibiotics). Shedding their outer wall, (which is the target of penicillin and related drugs), they could ward off attack and continue to exist in the body. . . .”
Note that Unit 731 personnel and their files were put to work for the United States after World War II, much like the Project Paperclip scientists from Germany.